| Product Code: ETC9972608 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United States continues to import significant amounts of oxytocin, with key suppliers including Austria, Metropolitan France, Italy, Germany, and Brazil. Despite the low concentration levels indicated by the Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) for the period 2020-2024 is notably negative at -31.87%. Furthermore, the growth rate from 2023 to 2024 experienced a sharp decline of -39.06%. These figures suggest a challenging market environment for oxytocin imports into the USA, potentially influenced by various factors impacting demand and supply dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Oxytocin Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Oxytocin Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Oxytocin Market - Industry Life Cycle |
3.4 United States (US) Oxytocin Market - Porter's Five Forces |
3.5 United States (US) Oxytocin Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 United States (US) Oxytocin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Oxytocin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of oxytocin in maternal healthcare |
4.2.2 Rising prevalence of conditions such as postpartum hemorrhage and labor induction |
4.2.3 Growing adoption of oxytocin in assisted reproductive technologies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for the approval and use of oxytocin |
4.3.2 Presence of alternative medications for the same indications |
4.3.3 Concerns regarding the safety and side effects of oxytocin use |
5 United States (US) Oxytocin Market Trends |
6 United States (US) Oxytocin Market, By Types |
6.1 United States (US) Oxytocin Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Oxytocin Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 United States (US) Oxytocin Market Revenues & Volume, By Antepartum, 2021- 2031F |
6.1.4 United States (US) Oxytocin Market Revenues & Volume, By Postpartum, 2021- 2031F |
6.2 United States (US) Oxytocin Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Oxytocin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 United States (US) Oxytocin Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.2.4 United States (US) Oxytocin Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 United States (US) Oxytocin Market Import-Export Trade Statistics |
7.1 United States (US) Oxytocin Market Export to Major Countries |
7.2 United States (US) Oxytocin Market Imports from Major Countries |
8 United States (US) Oxytocin Market Key Performance Indicators |
8.1 Number of clinical trials testing new applications of oxytocin |
8.2 Adoption rate of oxytocin in obstetric and gynecological practices |
8.3 Investment in research and development of oxytocin formulations |
9 United States (US) Oxytocin Market - Opportunity Assessment |
9.1 United States (US) Oxytocin Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 United States (US) Oxytocin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Oxytocin Market - Competitive Landscape |
10.1 United States (US) Oxytocin Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Oxytocin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |